OpenLB
Open Library of Bioscience
Advanced Search
3 Biotech
May, 2017;7 (1): 32.

Streptomyces artemisiae MCCB 248 isolated from Arctic fjord sediments has unique PKS and NRPS biosynthetic genes and produces potential new anticancer natural products.

M Dhaneesha, C Benjamin Naman, K P Krishnan, Rupesh Kumar Sinha, P Jayesh, Valsamma Joseph, I S Bright Singh, William H Gerwick, T P Sajeevan
Author Information
  1. M Dhaneesha: National Centre for Aquatic Animal Health, Cochin University of Science and Technology, Fine Arts Avenue, Kochi, Kerala, 682 016, India.
  2. C Benjamin Naman: Center for Marine Biotechnology and Biomedicine, Scripps Institution of Oceanography, University of California, La Jolla, San Diego, CA, 92093, USA.
  3. K P Krishnan: National Centre for Antarctic and Ocean Research, Headland Sada, Vasco da Gama, Goa, 403804, India.
  4. Rupesh Kumar Sinha: National Centre for Antarctic and Ocean Research, Headland Sada, Vasco da Gama, Goa, 403804, India.
  5. P Jayesh: National Centre for Aquatic Animal Health, Cochin University of Science and Technology, Fine Arts Avenue, Kochi, Kerala, 682 016, India.
  6. Valsamma Joseph: National Centre for Aquatic Animal Health, Cochin University of Science and Technology, Fine Arts Avenue, Kochi, Kerala, 682 016, India.
  7. I S Bright Singh: National Centre for Aquatic Animal Health, Cochin University of Science and Technology, Fine Arts Avenue, Kochi, Kerala, 682 016, India.
  8. William H Gerwick: Center for Marine Biotechnology and Biomedicine, Scripps Institution of Oceanography, University of California, La Jolla, San Diego, CA, 92093, USA.
  9. T P Sajeevan: National Centre for Aquatic Animal Health, Cochin University of Science and Technology, Fine Arts Avenue, Kochi, Kerala, 682 016, India. sajeev@cusat.ac.in.
PMID: 28401470 DOI: 10.1007/s13205-017-0610-3

Abstract

After screening marine actinomycetes isolated from sediment samples collected from the Arctic fjord Kongsfjorden for potential anticancer activity, an isolate identified as Streptomyces artemisiae MCCB 248 exhibited promising results against the NCI-H460 human lung cancer cell line. H460 cells treated with the ethyl acetate extract of strain MCCB 248 and stained with Hoechst 33342 showed clear signs of apoptosis, including shrinkage of the cell nucleus, DNA fragmentation and chromatin condensation. Further to this treated cells showed indications of early apoptotic cell death, including a significant proportion of Annexin V positive staining and evidence of DNA damage as observed in the TUNEL assay. Amplified PKS 1 and NRPS genes involved in secondary metabolite production showed only 82% similarity to known biosynthetic genes of Streptomyces, indicating the likely production of a novel secondary metabolite in this extract. Additionally, chemical dereplication efforts using LC-MS/MS molecular networking suggested the presence of a series of undescribed tetraene polyols. Taken together, these results revealed that this Arctic S. artemisiae strain MCCB 248 is a promising candidate for natural products drug discovery and genome mining for potential anticancer agents.

Keywords

Actinomycetes Anticancer Apoptosis Natural products Streptomyces

References

J Antibiot (Tokyo). 2015 Mar;68(3):185-90 [PMID: 25204346]
Int J Syst Evol Microbiol. 2010 Jan;60(Pt 1):27-32 [PMID: 19648351]
J Natl Cancer Inst. 1990 Jul 4;82(13):1107-12 [PMID: 2359136]
J Antibiot (Tokyo). 2005 Jan;58(1):1-26 [PMID: 15813176]
Mar Drugs. 2010 Apr 23;8(4):1469-81 [PMID: 20479985]
Mar Drugs. 2013 Aug 13;11(8):2882-93 [PMID: 23945600]
Microb Ecol. 2005 Jan;49(1):10-24 [PMID: 15614464]
Angew Chem Int Ed Engl. 2003 Jan 20;42(3):355-7 [PMID: 12548698]
Extremophiles. 2006 Jun;10(3):181-9 [PMID: 16538400]
J Org Chem. 2009 Jan 16;74(2):675-84 [PMID: 19132943]
Mar Drugs. 2012 Oct 29;10(11):2388-402 [PMID: 23203266]
Mol Biol Evol. 2013 Dec;30(12):2725-9 [PMID: 24132122]
J Org Chem. 2015 Aug 21;80(16):7849-55 [PMID: 26222145]
Appl Environ Microbiol. 2005 May;71(5):2232-8 [PMID: 15870305]
Mar Drugs. 2014 Mar 06;12(3):1281-97 [PMID: 24663116]
Mar Drugs. 2008 Jan 23;6(1):12-24 [PMID: 18648671]
Bioorg Med Chem. 2003 Aug 5;11(16):3401-5 [PMID: 12878134]
Cancer Biol Ther. 2007 Sep;6(9):1413-21 [PMID: 17786034]
Mar Drugs. 2011;9(5):772-89 [PMID: 21673888]
Nat Biotechnol. 2016 Aug 9;34(8):828-37 [PMID: 27504778]
Nat Protoc. 2006;1(3):1112-6 [PMID: 17406391]
Cardiovasc Res. 2000 Feb;45(3):528-37 [PMID: 10728374]
Curr Opin Microbiol. 2006 Jun;9(3):245-51 [PMID: 16675289]
J Ind Microbiol Biotechnol. 2006 Feb;33(2):84-7 [PMID: 16096834]
Mar Drugs. 2012 Dec 27;11(1):33-9 [PMID: 23271423]
J Am Chem Soc. 2006 Feb 8;128(5):1622-32 [PMID: 16448135]
J Nat Prod. 2012 May 25;75(5):959-67 [PMID: 22574670]
Cell. 2002 Jan 25;108(2):153-64 [PMID: 11832206]

Grants

  1. R01 GM065490/NIGMS NIH HHS
  2. T32 CA009523/NCI NIH HHS
Journal Article

Word Cloud

Similar Articles

Cited By